Possibility of age regulation of the natriuretic peptide C-receptor in human platelets
- 1 January 2001
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 24 (1) , 8-16
- https://doi.org/10.1007/bf03343802
Abstract
Natriuretic peptide binding sites on platelets have been hypothesized to act as clearance receptors; however, there is no clear definition of the function of this receptor. The aim of the study was: 1) to characterize natriuretic peptide receptors in human platelets by original competition study; 2) to evaluate a possible age modulation of these binding sites, since a delayed clearance of ANP in the elderly has been observed. The binding of 125I-ANP to intact platelets was completely inhibited by h-ANP, h-BNP, h-CNP and c-ANP, the selective ligand of the clearance receptor. IC50 values were 0.089±0.029, 0.703±0.104 and 1.19±0.13, 3.84±0.04 nmol/l, mean±SE, respectively (pmax 13.6±0.92 fmol/109 platelets (mean±SE), (no.=46, mean age 41.7±2.1 years). Bmax was significantly reduced in older subjects (no.=25, mean age 53.2±1.5 years) with respect to the younger group (no.=21, mean age 28.0±0.87 years): 11.4±1.1 vs 16.1±1.4 fmol/109 cells, p=0.0096, respectively; moreover, a significant inverse relationship between Bmax and the subject’s age was observed. This observation suggests a possible reduction of the natriuretic peptide clearance with aging, associated to a significant increase of plasma levels of natriuretic peptides.This publication has 49 references indexed in Scilit:
- Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humansEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- C‐type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF‐R2/ANP‐C receptorsFEBS Letters, 1995
- The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathyEuropean Journal of Clinical Investigation, 1993
- Inhibition of endothelial cell clearance of atrial natriuretic peptide by cyclic GMP treatmentBiochemical and Biophysical Research Communications, 1992
- Calculating receptor number from binding experiments using same compound as radioligand and competitorTrends in Pharmacological Sciences, 1989
- Platelet binding sites for atrial natriuretic factor in humans. Characterization and effects of sodium intake.Hypertension, 1986
- Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in manLife Sciences, 1986
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981
- Characterization of α2-adrenergic receptors on human platelets using [3H]yohimbineBiochemical and Biophysical Research Communications, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973